Monopar Therapeutics (MNPR) Non-Current Assets: 2016-2020
Historic Non-Current Assets for Monopar Therapeutics (MNPR) over the last 2 years, with Sep 2020 value amounting to $68,858.
- Monopar Therapeutics' Non-Current Assets was N/A to $68,858 in Q3 2020 from the same period last year, while for Sep 2020 it was $68,858, marking a year-over-year change of. This contributed to the annual value of $122,381 for FY2019, which is 86.18% up from last year.
- Latest data reveals that Monopar Therapeutics reported Non-Current Assets of $68,858 as of Q3 2020, which was down 5.74% from $73,050 recorded in Q2 2020.
- In the past 5 years, Monopar Therapeutics' Non-Current Assets ranged from a high of $800,393 in Q4 2016 and a low of $65,731 during Q4 2018.
- Its 3-year average for Non-Current Assets is $293,209, with a median of $122,381 in 2020.
- Per our database at Business Quant, Monopar Therapeutics' Non-Current Assets plummeted by 91.78% in 2018 and then skyrocketed by 86.18% in 2019.
- Over the past 5 years, Monopar Therapeutics' Non-Current Assets (Quarterly) stood at $800,393 in 2016, then fell by 0.05% to $800,031 in 2017, then crashed by 91.78% to $65,731 in 2018, then soared by 86.18% to $122,381 in 2019, then reached $68,858 in 2020.
- Its Non-Current Assets stands at $68,858 for Q3 2020, versus $73,050 for Q2 2020 and $122,381 for Q1 2020.